- Record: found
- Abstract: found
- Article: not found
Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the change in drusen volume following treatment with eculizumab, a systemic inhibitor of complement component 5.